CY1122568T1 - Διαχειριση της οστεοπορωσης me hmw peg - Google Patents
Διαχειριση της οστεοπορωσης me hmw pegInfo
- Publication number
- CY1122568T1 CY1122568T1 CY20191100930T CY191100930T CY1122568T1 CY 1122568 T1 CY1122568 T1 CY 1122568T1 CY 20191100930 T CY20191100930 T CY 20191100930T CY 191100930 T CY191100930 T CY 191100930T CY 1122568 T1 CY1122568 T1 CY 1122568T1
- Authority
- CY
- Cyprus
- Prior art keywords
- osteoporosis
- management
- hmw peg
- administration
- animal
- Prior art date
Links
- 208000001132 Osteoporosis Diseases 0.000 title abstract 2
- 208000020084 Bone disease Diseases 0.000 abstract 1
- 208000029725 Metabolic bone disease Diseases 0.000 abstract 1
- 206010049088 Osteopenia Diseases 0.000 abstract 1
- 239000002202 Polyethylene glycol Substances 0.000 abstract 1
- 230000002496 gastric effect Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 229920001223 polyethylene glycol Polymers 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Reproductive Health (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Immunology (AREA)
- Endocrinology (AREA)
- Pregnancy & Childbirth (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Gynecology & Obstetrics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361798481P | 2013-03-15 | 2013-03-15 | |
| PCT/US2014/028832 WO2014144425A1 (en) | 2013-03-15 | 2014-03-14 | Managing osteoporosis with hmw peg |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1122568T1 true CY1122568T1 (el) | 2021-01-27 |
Family
ID=51537706
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20191100930T CY1122568T1 (el) | 2013-03-15 | 2019-09-05 | Διαχειριση της οστεοπορωσης me hmw peg |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US10045949B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2968159B1 (cg-RX-API-DMAC7.html) |
| JP (3) | JP6275239B2 (cg-RX-API-DMAC7.html) |
| AU (2) | AU2014229082C1 (cg-RX-API-DMAC7.html) |
| CY (1) | CY1122568T1 (cg-RX-API-DMAC7.html) |
| DK (1) | DK2968159T3 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2744828T3 (cg-RX-API-DMAC7.html) |
| HU (1) | HUE045032T2 (cg-RX-API-DMAC7.html) |
| PL (1) | PL2968159T3 (cg-RX-API-DMAC7.html) |
| PT (1) | PT2968159T (cg-RX-API-DMAC7.html) |
| WO (1) | WO2014144425A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111419823B (zh) * | 2020-04-30 | 2022-03-29 | 上海公谊药业有限公司 | 一种延胡索酸泰妙菌素肠溶微丸及其制备方法和用途 |
| NL1044084B1 (nl) | 2021-07-05 | 2023-01-11 | Evers Agro B V | Mestinjecteur |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH10338646A (ja) | 1996-08-26 | 1998-12-22 | Takeda Chem Ind Ltd | 骨形成促進医薬組成物 |
| WO2004047778A1 (en) * | 2002-11-26 | 2004-06-10 | Uc Tech | Materials and methods for preventing and treating microbe-mediated epithelial disorders |
| JPWO2004105825A1 (ja) | 2003-01-10 | 2006-07-20 | 多木化学株式会社 | 骨形成用生体材料、該材料を含む注入用製剤、及び該材料を調製するためのキット、並びにこれらを用いる骨形成方法 |
| EP1744767A4 (en) | 2004-04-20 | 2008-08-13 | Univ Chicago | THERAPEUTIC DELIVERY SYSTEM WITH PEG-LIKE CONNECTION WITH HIGH MOLECULAR WEIGHT |
| US8840933B2 (en) * | 2006-05-03 | 2014-09-23 | Warsaw Orthopedic, Inc. | Method of treating neuronal injury by administering magnesium chloride and PEG |
| US9675696B2 (en) * | 2006-11-14 | 2017-06-13 | Warsaw Orthopedic, Inc. | Method and use for increasing efficacy of anti-adhesive compositions in controlling inflammation and pain |
| US8153112B2 (en) * | 2007-08-03 | 2012-04-10 | Warsaw Orthopedic, Inc. | Compositions and methods for treating cavity conditions |
| MX2011009988A (es) * | 2009-03-23 | 2011-11-18 | Univ Chicago | Metodos para la prevencion y el tratamiento de trastornos epiteliales inducidos por radiaciones. |
| EP2468265A3 (en) * | 2010-12-04 | 2013-01-02 | DEEF Pharmaceutical Industries Co. | Homogeneous preparations containing vitamin D |
-
2014
- 2014-03-14 US US14/768,741 patent/US10045949B2/en active Active
- 2014-03-14 DK DK14764671.5T patent/DK2968159T3/da active
- 2014-03-14 HU HUE14764671A patent/HUE045032T2/hu unknown
- 2014-03-14 JP JP2016502913A patent/JP6275239B2/ja active Active
- 2014-03-14 EP EP14764671.5A patent/EP2968159B1/en active Active
- 2014-03-14 PL PL14764671T patent/PL2968159T3/pl unknown
- 2014-03-14 AU AU2014229082A patent/AU2014229082C1/en active Active
- 2014-03-14 PT PT147646715T patent/PT2968159T/pt unknown
- 2014-03-14 ES ES14764671T patent/ES2744828T3/es active Active
- 2014-03-14 WO PCT/US2014/028832 patent/WO2014144425A1/en not_active Ceased
-
2017
- 2017-02-13 JP JP2017024048A patent/JP2017082009A/ja not_active Withdrawn
-
2018
- 2018-07-30 JP JP2018142353A patent/JP6619849B2/ja active Active
- 2018-08-10 US US16/101,145 patent/US20190015353A1/en not_active Abandoned
- 2018-10-19 AU AU2018250501A patent/AU2018250501B2/en active Active
-
2019
- 2019-09-05 CY CY20191100930T patent/CY1122568T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP2968159B1 (en) | 2019-06-12 |
| EP2968159A1 (en) | 2016-01-20 |
| US20160000730A1 (en) | 2016-01-07 |
| JP2017082009A (ja) | 2017-05-18 |
| HUE045032T2 (hu) | 2019-12-30 |
| PL2968159T3 (pl) | 2019-11-29 |
| EP2968159A4 (en) | 2016-09-28 |
| PT2968159T (pt) | 2019-10-01 |
| AU2014229082C1 (en) | 2019-01-17 |
| US20190015353A1 (en) | 2019-01-17 |
| JP2016513738A (ja) | 2016-05-16 |
| JP2018162328A (ja) | 2018-10-18 |
| AU2018250501B2 (en) | 2020-06-25 |
| JP6275239B2 (ja) | 2018-02-07 |
| US10045949B2 (en) | 2018-08-14 |
| AU2018250501A1 (en) | 2018-11-15 |
| JP6619849B2 (ja) | 2019-12-11 |
| AU2014229082A1 (en) | 2015-11-05 |
| WO2014144425A1 (en) | 2014-09-18 |
| AU2014229082B2 (en) | 2018-07-19 |
| ES2744828T3 (es) | 2020-02-26 |
| DK2968159T3 (da) | 2019-08-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1124729T1 (el) | Φαρμακοτεχνικες μορφες του ενζαλουταμιδιου | |
| CY1122329T1 (el) | Anti-siglec-8 αντισωματα και μeθοδοι χρhσεως αυτων | |
| CY1123476T1 (el) | Τροποποιητες πυρηνικης μεταφορας και χρησεις αυτων | |
| CY1122786T1 (el) | Δοσολογικα σχηματα για ενωσεις κατηγοριας εχινοκανδινης | |
| CY1121928T1 (el) | Φαρμακευτικη συνθεση υδροχλωρικης s-κεταμινης | |
| CY1123953T1 (el) | Καθυστερημενης απελευθερωσης συνθεσεις λινακλοτιδης | |
| CY1122796T1 (el) | Βελτιωμενες φαρμακοτεχνικες μορφες αδενοϊων | |
| EP3589215A4 (en) | TODLESS ORTHOPEDIC STABILIZATION SYSTEM | |
| BR112017010173A2 (pt) | composição para tratamento de tecido | |
| CY1121736T1 (el) | Άλατα aramchol | |
| CY1119110T1 (el) | Ρυθμιστες ρ2χ7 | |
| EA201691988A1 (ru) | Производные бороновой кислоты и их терапевтическое применение | |
| CY1119489T1 (el) | Υποκατεστημενη πιπεριδυλο-αιθυλο-πυριμιδινη ως αναστολεας της ο-ακυλο τρανσφερασης της γκρελινης | |
| EA201691259A1 (ru) | РЕГУЛЯТОРЫ Nrf2 | |
| UY34763A (es) | Inhibidores de la agregación plaquetaria | |
| CR20160419A (es) | Nuevos compuestos biciclicos | |
| EA201692301A1 (ru) | Производные бороновой кислоты и их терапевтическое применение | |
| EA201490806A1 (ru) | Комбинированный состав двух противовирусных соединений | |
| EA201591728A1 (ru) | Гетероциклические соединения и способы их применения | |
| EA201591004A1 (ru) | Производные бороновой кислоты и их терапевтическое применение | |
| MX376869B (es) | Metodos utiles en la sintesis de analogos de halicondrina b. | |
| EA201401077A1 (ru) | Биспецифические антитела к человеческому tweak и человеческому il17 и их применения | |
| BR112017010177A2 (pt) | composição para tratamento de tecido | |
| CY1119151T1 (el) | Ν-(4-(αζαϊνδαζολ-6-υλ)-φαινυλ)-σουλφοναμιδiα και η χρηση τους ως φαρμακα | |
| CY1124995T1 (el) | Μεθοδοι για τη μειωση της εκπτωσης στη ζωτικη χωρητικοτητα |